The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $106,624 in first-year total cost, median $47,244.
Most frequent study sections
- Special Emphasis Panel[ZRG1 F10B-B (20)]2
- Special Emphasis Panel[ZRG1-F10B-B(20)L]1
Most frequent institutions
- LEIDEN UNIVERSITY MEDICAL CENTER2
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Modulating Skeletal Muscle Regeneration by Delivery of Myeloid Lineage Cells1F32AR065845-01 | WELC, STEVEN S | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $51,530 | ZRG1 |
| 2014 | Epigenetic regulation in facioscapulohumeral muscular dystrophy type 2 (FSHD2)1F32AR067050-01 | MASON, AMANDA | LEIDEN UNIVERSITY MEDICAL CENTER | $47,244 | ZRG1 |
| 2014 | Epigenetic regulation in facioscapulohumeral muscular dystrophy type 2 (FSHD2)1F32AR067050-01X1 | MASON, AMANDA | LEIDEN UNIVERSITY MEDICAL CENTER | $7,850 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.